BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30189347)

  • 1. Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?
    Pannemans J; Corsetti M
    Curr Opin Pharmacol; 2018 Dec; 43():53-58. PubMed ID: 30189347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA; Sheridan EA
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

  • 11. Naldemedine (Symproic) for opioid-induced constipation.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):196-198. PubMed ID: 29186083
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL
    Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxegol for opioid-induced constipation in patients with noncancer pain.
    Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
    N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
    Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H; Mahan RJ
    Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced constipation in chronic noncancer pain.
    Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.